TBI at a glance
TrueBlue, Inc. (TBI, SEC CIK 768899) filed its latest 10-K annual report on February 18, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and Form 4 insider filings as recently as November 20, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 28, 2025 (FY2025), TrueBlue, Inc. (TBI) reported revenue of $1.6 billion (up 3.1% from FY2024) and a net loss of $48.0 million. Diluted EPS was -$1.61.
- As of September 30, 2026, 29 institutional investment managers tracked by SignalX reported holding TrueBlue, Inc. (TBI) shares worth $91.1 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Ferencz Garrett on November 12, 2026 of 600 shares at $12.34 per share.
- In the last 90 days, TBI insiders reported 0 open-market purchases ($0) and 3 open-market sales ($177K) on Form 4, a net sale of $177K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $1.6B
- +3.1% vs prior year
- Insiders · 90 days
- 0 buys · 3 sells
- Net −$177K
- 13F holders
- 29 funds
- $91.1M · +2 vs prior quarter
- Latest 8-K
- Nov 4, 2026
- Item 2.02 · Item 7.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 27, 2026
Risk Factors
- Newly updated governance risk: unsolicited proposals to buy all or part of TrueBlue triggered expanded takeover-related disclosures
- Most material legal risk: Washington law and shareholder-rights provisions may delay or prevent a change of control
- Operational risk: one client represents over 10% of consolidated revenue, creating concentration exposure
- Market risk: acquisition proposals and activist campaigns could increase stock-price volatility
- Financial risk: slower collection from concentrated receivables could weaken cash flows
Management Discussion & Analysis
- Q3 revenue $520.7M, up 20.7% YoY from $431.3M
- Gross margin 20.5% vs 22.7% YoY; operating margin 2.3% vs approximately 0% YoY
- Best segment PeopleReady: revenue $338.0M, up 34.4%; segment margin 5.9% vs 3.2%
- Cash $19.8M, debt $102.3M, unused borrowing capacity $66.5M
- Operating cash flow used $56.4M; no share repurchases, $33.5M authorization remaining
- Headwinds: lower-margin energy mix, higher workers’ compensation costs, stabilizing OnSite and healthcare demand
AI summary of the TBI 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Q3 FY2026 results for quarter ended September 27, 2026, with Q4 and full-year outlook
- Management conference call scheduled November 4, 2026, at 2:00 p.m. Pacific Time
Item 7.01: Regulation FD Disclosure
- Investor roadshow presentation attached as Exhibit 99.3
- Presentation intended for Q3 2026 earnings discussion and future investor conferences
Item EX-99.3: Item EX-99.3
- Investor roadshow outlines growth strategy across staffing and global RPO, emphasizing market expansion, sales execution, digital transformation and efficiency
- 2025 revenue $1.6B, with 10M+ people connected to work and 3M+ clients served
Item EX-99.2: Item EX-99.2
- Q3 2026 revenue $521M, up 21%, led by PeopleReady revenue growth of 34% to $338M
- GAAP net income $9.2M, or $0.28 per share, versus a $1.9M loss in Q3 2025
Item EX-99.1: Item EX-99.1
- Q3 revenue $521 million, up 21%, marking the fifth consecutive quarter of top-line growth
- Net income $9 million, or $0.28 per share, versus a $2 million loss and $0.06 loss per share
Item EX-99.1: Item EX-99.1
- Elizabeth Castro Gulacsy appointed independent director effective October 26, 2026
- Former United Parks & Resorts CFO adds public-company finance and cost-discipline expertise
Item 8.01: Other Events
- TrueBlue appointed Ms. Castro Gulacsy, making leadership composition the primary investor-relevant development
- Appointment details, including role and responsibilities, are provided in Exhibit 99.1
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Elizabeth Castro Gulacsy appointed director effective October 26, 2026, expanding the Board to ten members
- Audit Committee appointment adds public-company finance, accounting, debt refinancing, and risk-management expertise
Item 2.02: Results of Operations and Financial Condition
- Q2 fiscal 2026 results cover the period ended June 28, 2026
- Third-quarter and fiscal-year 2026 outlook included in Exhibit 99.1
Item 7.01: Regulation FD Disclosure
- Investor Roadshow Presentation attached as Exhibit 99.3 for Q2 2026 earnings discussion and future conferences
- Presentation available on TrueBlue’s website, expanding investor access to management’s messaging
Item EX-99.3: Item EX-99.3
- Investor roadshow highlights $1.6B 2025 revenue, $133M share repurchases, and 10M+ people connected with work
- Staffing portfolio spans PeopleReady, PeopleManagement, and PeopleSolutions, with 2025 revenue shares of 55%, 34%, and 11%
Item EX-99.1: Item EX-99.1
- Q2 revenue $443 million, up 12%, signaling renewed growth across skilled verticals and core on-demand staffing
- Adjusted EBITDA $11 million, up from $3 million, with margin improving to 2.6% from 0.7%
Item EX-99.2: Item EX-99.2
- Q2 revenue $443M, up 12%, led by skilled businesses and renewed growth in core on-demand staffing
- GAAP net loss widened to $3.4M from $0.2M, including a $3M non-cash loss on held-for-sale assets
AI summaries of TBI 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for TBI
Don't miss the next TBI filing
- Alerts as it files. A push when TBI files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut TBI, by share count.
- Ask anything. An AI agent that reads every TBI filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Ferencz Garrett | J | Nov 18, 2026 | 11,814 | $11.90 |
| Ferencz Garrett | Sell | Nov 12, 2026 | 600 | $12.34 |
| Ferencz Garrett | Sell | Nov 10, 2026 | 2,400 | $12.26 |
| Ferencz Garrett | Sell | Nov 9, 2026 | 11,814 | $11.90 |
| Gulacsy Elizabeth | A | Nov 2, 2026 | 4,313 | - |
| Schweihs Carl | F | Nov 1, 2026 | 1,710 | $9.77 |
| Owen Taryn R | F | Oct 3, 2026 | 1,436 | $9.18 |
| Owen Taryn R | F | Oct 2, 2026 | 2,472 | $9.18 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $1.6B | $1.6B |
| Gross Profit | - | $406.4M | $367.8M |
| Operating Income | - | -$92.8M | -$46.6M |
| Net Income | - | -$125.7M | -$48.0M |
| Gross Margin | - | 25.9% | 22.8% |
| Op. Margin | - | -5.9% | -2.9% |
| Net Margin | - | -8.0% | -3.0% |
| Balance Sheet | |||
| Total Assets | $899.4M | $675.4M | $638.7M |
| Equity | $457.9M | $315.4M | $274.6M |
| ROE | - | -39.9% | -17.5% |
| Per Share | |||
| EPS | - | $-4.17 | $-1.61 |
| Cash Flow | |||
| Operating CF | - | -$17.1M | -$58.0M |
| CapEx | - | $24.2M | $15.7M |
Source: XBRL data in TrueBlue, Inc. (TBI)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate TBI share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 29 | $91.1M |
| Q2 2026 | 27 | $64.9M |
| Q1 2026 | 28 | $33.6M |
| Q4 2025 | 25 | $49.7M |
| Q3 2025 | 25 | $69.8M |
| Q2 2025 | 25 | $74.7M |
| Q1 2025 | 22 | $59.2M |
| Q4 2024 | 19 | $92.7M |
- JPMorgan Chase & Co+144.9K (+61%)
- D.E. Shaw & Co+120.7K (+20%)
- Franklin Resources+105.5K (+321%)
- Two Sigma Investments+103.2K (+96%)
- AQR Capital Management+91.0K (+39%)
- IES Holdings, Inc.−210.8K (-16%)
- Prudential Financial−112.9K (-31%)
- Ameriprise Financial−79.9K (-70%)
- Bank of America Corp−66.4K (-21%)
- Raymond James Financial−40.0K (-75%)
- Millennium Management+288.3K
- Citadel Advisors LLC+203.3K
- Mangrove Partners+10.3K
- FMR LLC (Fidelity)−8.0K
Source: 13F-HR filings on SEC EDGAR (aggregated from 200 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
TBI filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 20, 2026 | - | - | - |
| 4 | Nov 16, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 8-K | Nov 4, 2026 | - | Analysis | - |
| 10-Q | Nov 4, 2026 | Sep 27, 2026 | Analysis | |
| 4 | Nov 3, 2026 | - | - | - |
| 4 | Nov 3, 2026 | - | - | - |
| 8-K | Oct 26, 2026 | - | Analysis | - |
| 4 | Oct 6, 2026 | - | - | - |
| 10-Q | Aug 4, 2026 | Jun 28, 2026 | Analysis | |
| 8-K | Aug 4, 2026 | - | Analysis | - |
| 4 | Jun 8, 2026 | - | - | |
| 8-K | May 15, 2026 | - | Analysis | |
| 8-K | May 6, 2026 | - | Analysis | |
| 8-K | May 5, 2026 | - | Analysis | - |
| 10-Q | May 5, 2026 | Mar 29, 2026 | Analysis | |
| 8-K | Apr 13, 2026 | - | Analysis | - |
| 4 | Apr 7, 2026 | - | - | - |
| 4 | Feb 26, 2026 | - | - | - |
| 4 | Feb 26, 2026 | - | - | - |
| 4 | Feb 25, 2026 | - | - | - |
| 4 | Feb 25, 2026 | - | - | - |
| 4 | Feb 25, 2026 | - | - | - |
| 4 | Feb 25, 2026 | - | - | - |
| 4 | Feb 24, 2026 | - | - | - |
Related Information Technology companies
- AMN · AMN HEALTHCARE SERVICES INCServices-Help Supply Services
- ASGN · ASGN IncServices-Help Supply Services
- BBSI · BARRETT BUSINESS SERVICES INCServices-Help Supply Services
- CCRN · CROSS COUNTRY HEALTHCARE INCServices-Help Supply Services
- NSP · INSPERITY, INC.Services-Help Supply Services
- KELYA · KELLY SERVICES INCServices-Help Supply Services
- KFRC · KFORCE INCServices-Help Supply Services
- RCMT · RCM TECHNOLOGIES, INC.Services-Help Supply Services
TBI SEC filings: frequently asked questions
Are TBI insiders buying or selling?
In the last 90 days, TrueBlue, Inc. (TBI) officers, directors and 10% owners reported no open-market purchases and 3 open-market sales worth $177,415 by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold TBI stock?
As of September 30, 2026, the largest TrueBlue, Inc. (TBI) holders among the 13F filers tracked by SignalX were BlackRock ($20.6 million), Vanguard Capital Management LLC ($11.2 million), IES Holdings, Inc. ($9.9 million), D.E. Shaw & Co ($6.7 million), State Street Corp ($6.0 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was TBI's revenue in fiscal year 2025?
For the fiscal year ended December 28, 2025 (FY2025), TrueBlue, Inc. (TBI) reported revenue of $1.6 billion (up 3.1% from FY2024) and a net loss of $48.0 million. Diluted EPS was -$1.61. The figures come from the XBRL data in the 10-K.
What did TBI report in its latest 8-K?
TrueBlue, Inc. (TBI) filed an 8-K on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). Q3 FY2026 results for quarter ended September 27, 2026, with Q4 and full-year outlook.
What are the latest TBI SEC filings?
TrueBlue, Inc. (TBI) filed its latest 10-K annual report on February 18, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and a Form 4 insider filing on November 20, 2026.
What is TBI's SEC CIK number?
TrueBlue, Inc. (TBI)'s SEC Central Index Key (CIK) is 768899. EDGAR lists every TBI filing under that number.
Ask anything about TBI
The research agent reads TBI's filings, financials, insider trades and 13F holders, then answers with sources.